Second line treatment for EGFR wild-type advanced NSCLC: the jury is still out.
| Data(s) |
2014
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_5BA494506491 isbn:1872-8332 (Electronic) pmid:24685307 doi:10.1016/j.lungcan.2014.03.012 isiid:000338413000020 |
| Idioma(s) |
en |
| Fonte |
Lung Cancer, vol. 84, no. 3, pp. 314-315 |
| Tipo |
info:eu-repo/semantics/article article |
